Description
This is an extension of a study of the safety and effectiveness of an investigational drug to treat Amyotrophic Lateral Sclerosis (ALS)
Overview
This study is designed to provide longer term access to the new investigational drug to those patients who participated in the another ALS study called CENTAUR study. The study will assess longer term safety and potential of this Investigational drug therapy. The individual components of this drug have been tested in small clinical trials of ALS patients and was found to be safe and well-tolerated, and effective.
What we're hoping for
The purpose of this study is to determine the safety and effectiveness of an Investigational drug that is a fixed combination of two different drugs as a treatment for ALS.
Additional Information
ClinicalTrials.gov Identifier: NCT03127514